diabetes prevention

Early Weight Loss in Impaired Glucose Tolerance Significantly Lowers Long-term Cardiovascular and Mortality Risks: Insights from the Da Qing Diabetes Prevention Study

By MedXY 08/24/2026

Early weight loss after impaired glucose tolerance diagnosis is linked to markedly reduced long-term risk of cardiovascular events and death, underscoring the importance of early lifestyle interventions in prediabetes management.

Diabetes & Endocrinology news Public Health

Staging Intermediate Hyperglycaemia to Improve Type 2 Diabetes Prevention: Findings from the ELSA-Brasil Study

By MedXY 05/13/2026

The ELSA-Brasil study found that staging intermediate hyperglycaemia with fasting glucose plus 1-hour glucose better predicted type 2 diabetes than fasting glucose plus HbA1c, and a clinical risk score reduced unnecessary testing.

Diabetes & Endocrinology Internal Medicine news

Beyond the High-Protein Hype: Why Moderate Diets May Be the Secret to Reversing Prediabetes

By MedXY 01/10/2026

A major long-term trial reveals that a moderate-protein, moderate-glycaemic index diet is more effective for sustaining prediabetes remission than high-protein alternatives, regardless of total weight loss.

Diabetes & Endocrinology news

Prediabetes Remission Without Weight Loss: Rethinking Targets to Prevent Type 2 Diabetes

By MedXY 11/12/2025

A post hoc analysis of PLIS and replication in the DPP show that achieving prediabetes remission—normalization of glucose—can prevent type 2 diabetes even without net weight loss, via improved insulin sensitivity, β‑cell function and favorable adipose redistribution.

AI Clinical Updates Diabetes & Endocrinology news

Evaluating AI-Led vs Human-Led Lifestyle Interventions in Prediabetes: Evidence from a Randomized Clinical Trial of the Diabetes Prevention Program

By MedXY 10/29/2025

This review examines the first phase 3 randomized trial demonstrating that an AI-powered Diabetes Prevention Program lifestyle intervention is noninferior to human coaching in improving weight loss, HbA1c, and physical activity among adults with prediabetes and overweight or obesity.